Suppliers / Laxai Life Sciences

Laxai Life Sciences

India 351 employees Updated 9 July 2026

Laxai Life Sciences is an API manufacturer based in India. Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 14 March 2025 as NAI. Customs aggregates show $1.2M of exports covering 20 molecules to 4 destinations in 2025.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 14 March 2025 NAI US FDA
  • 3 August 2019 VAI US FDA
  • 24 April 2015 NAI US FDA
  • 16 April 2012 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Hyderabad, India Not on file
Medchal-Malkajgiri District, India 3002806664

What they file, and where

Molecule Regulators Docs
Raloxifene SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Raloxifene API

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA None 1
EMA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $361K 2
2025 Not reported $1.2M 4

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Laxai Life Sciences

Is Laxai Life Sciences FDA-registered?
One site operated by Laxai Life Sciences carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Laxai Life Sciences's last inspection go?
The most recent inspection on record closed on 14 March 2025 as NAI (No Action Indicated: nothing objectionable was found). 4 inspections are on file.
Where does Laxai Life Sciences manufacture?
2 registered sites are on record, in India (Hyderabad and Medchal-malkajgiri District). Every site is listed on this page with the register it came from.
What does Laxai Life Sciences make?
1 molecule is on record against Laxai Life Sciences, including Raloxifene. Each links through to that molecule's full manufacturer list.
Which regulators recognise Laxai Life Sciences's GMP?
Current GMP certificates are on record from US FDA and EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Laxai Life Sciences comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 14 March 2025.

Comparable suppliers

Apitoria Pharma shares 1 molecule Hetero shares 1 molecule Dr Reddy's Laboratories shares 1 molecule Alivus Life Sciences shares 1 molecule Olon shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts